COFEPRIS Market Entry: Authorizations to Sell Medicines in Mexico

KNR Abogados

To import and distribute medicines in Mexico, you need an importer domiciled in Mexico, a health license or notice of operation, a responsable sanitario, the product's marketing authorization (registro sanitario) plus the holder's consent if you are not the holder, and import permits. If the medicine contains narcotic drugs or psychotropic substances, the law limits which establishments may import it.

What COFEPRIS authorizations do you need to sell medicines in Mexico?

Sanitary control over the processing, import and export of medicines falls exclusively to the Ministry of Health (Secretaría de Salud), under article 194 of the General Health Law (Ley General de Salud, LGS), and the Ministry exercises it through COFEPRIS (article 17 Bis). Because “processing” includes distribution and storage (article 197), every link in the chain needs a health license (licencia sanitaria), a notice of operation (aviso de funcionamiento), a marketing authorization or a permit before operating.

In what order do the pieces fall into place?

  • Importer in Mexico: the importer must be domiciled in Mexico (article 285). A foreign legal entity that wishes to engage habitually in commercial activity in Mexico needs authorization from the Ministry of Economy (Secretaría de Economía), which is granted, among other requirements, if the entity establishes itself in Mexico or has an agency or branch there, under articles 17 and 17 A of the Foreign Investment Law (Ley de Inversión Extranjera, LIE). If you plan to incorporate a company, see company formation for foreign investors.
  • Establishment, license or notice: depending on its type (article 257) and its activity, the establishment needs a health license or a notice of operation (article 258); we explain this in health license and responsable sanitario.
  • Responsable sanitario: every establishment listed in article 257 must have a responsable sanitario (the licensed professional responsible for the establishment’s sanitary compliance), who must hold a registered professional degree (articles 259 and 260).
  • Marketing authorization: medicines require one (article 376), and it must already exist before they are imported for commercial purposes; if the importer is not the holder, it needs the holder’s consent, under article 131 of the Health Supplies Regulation (Reglamento de Insumos para la Salud, RIS).
  • Import permits and Importers’ Registry: importing the medicines specified in the agreement published in the Official Gazette of the Federation (Diario Oficial de la Federación, DOF) requires sanitary authorization (article 295 of the LGS), and anyone who brings goods into Mexico must be enrolled in the Importers’ Registry (Padrón de Importadores), under article 59, section IV, of the Customs Law (Ley Aduanera); we cover this in foreign trade and customs.

What changes if the medicine contains narcotic drugs or psychotropic substances?

The establishment requires a sanitary authorization (article 198, section I) and a license (articles 258 and 373), and article 290 grants authorization to import medicines containing narcotic drugs (estupefacientes) or psychotropic substances (psicotrópicos) “exclusively” to droguerías (licensed establishments that compound and sell medicines, including those containing narcotic drugs or psychotropic substances, as defined in article 257 of the LGS) and to authorized medicine-producing establishments, and empowers the Ministry of Health to authorize justified special cases. That is why the type of establishment is defined before the company is incorporated. We explain this in importing controlled medicines.

Can a foreign company invest in this activity?

As far as we have reviewed, the LIE allows foreign participation in any proportion (article 4), and its lists of reserved activities and activities subject to participation caps (articles 5 to 8) do not include the manufacture, import or distribution of medicines. You should still check whether article 9 applies (a resolution of the National Foreign Investment Commission, depending on the value of the assets), as well as registration under article 32 with the National Registry of Foreign Investment (Registro Nacional de Inversiones Extranjeras). For the broader picture, see foreign companies in Mexico and our life sciences and health law practice.

Updated November 2026.

This content is informational and does not constitute legal advice. Every case requires individual analysis.

Does this sound familiar?

Are you in this situation?

  • You are a pharmaceutical company or a foreign investor and want to sell finished medicines in Mexico, but you do not have a company here yet.
  • You are not sure whether your warehouse or distribution company needs a health license or whether a notice of operation is enough.
  • You do not know whether your company can hold the marketing authorization or whether you must work with its holder or with the product's manufacturer.
  • Your catalog includes medicines containing narcotic drugs or psychotropic substances, and you do not know how that changes the structure you need.
  • You have a candidate for responsable sanitario, but you have not confirmed that their profession meets the requirements of the General Health Law.
  • A local partner says they will handle everything, and you do not know which authorizations would be in their name rather than yours.
What is at stake

The cost of waiting

Operating without the required authorization

The health license must be applied for, and the notice of operation filed, before operations begin (articles 198 and 200 Bis of the LGS). Operating without them exposes you to safety measures, such as seizure of the product, and to sanctions such as a fine or closure (articles 404 and 417).

The wrong structure from day one

Who the importer is, who holds the marketing authorization and what type of establishment you operate are all interlinked. Fixing the structure later means redoing filings and, in some cases, the establishment itself.

Authorizations in a third party's name

When the local partner or distributor is the importer or holds the establishment's license, your company depends on them to operate, and any later changes must be reported to the authority.

Misclassifying the controlled product

For narcotic drugs and psychotropic substances, article 290 of the LGS grants import authorization to certain establishments and leaves special cases to the Ministry of Health. Assuming that any distributor can import them directly is a threshold mistake worth ruling out before you invest.

How we step in
01

Structure and importer's domicile

We work with you to define whether you will operate through a Mexican company or another vehicle, which entity will act as importer domiciled in Mexico, and which foreign investment requirements apply.

02

Type of establishment and license or notice

We analyze which activities your company will carry out and which category of article 257 of the General Health Law applies, to determine whether you need a health license or a notice of operation.

03

Responsable sanitario

We review the professional profile the law requires for your type of establishment, the designation and the notice to the authority, and how responsibility is shared with the owner.

04

Marketing authorization and holder's consent

We determine whether the product already has a marketing authorization in Mexico and who holds it, and what is needed to import it with the holder's consent or, if there is none, to obtain one.

05

Import permits and Importers' Registry

We review the sanitary import permits that apply to the product and your enrollment in the Importers' Registry (Padrón de Importadores), in coordination with your customs broker.

Relevant experience

We assist local companies and multinationals in the pharmaceutical sector with managing health licenses and notices of operation, marketing authorizations and import permits before COFEPRIS. Our work combines regulatory prevention with managing the relationship with the authority, coordinated with the company's legal, regulatory and operations teams.

Frequently asked questions

Your questions, answered

Can a foreign company invest in medicine distribution in Mexico?

As far as we have reviewed, the Foreign Investment Law (Ley de Inversión Extranjera) neither reserves the manufacture, import or distribution of medicines to Mexican nationals nor caps foreign participation in them. Its article 9 does require a favorable resolution from the National Foreign Investment Commission (Comisión Nacional de Inversiones Extranjeras) for foreign participation to exceed 49% of the capital of a Mexican company whose assets exceed the amount that Commission sets each year.

In what order do you obtain the authorizations to import medicines?

In our reading, you first define who will be the importer, which must be domiciled in Mexico (article 285 of the General Health Law); then the type of establishment, its license or notice and its responsable sanitario; and, with that in place, the product's marketing authorization, which must exist before the product is imported for commercial purposes (article 131 of the Health Supplies Regulation), and the import permits. The specific order depends on each case.

Can my foreign company import medicines without a presence in Mexico?

The General Health Law requires the importer of medicines to be domiciled in Mexico (article 285). In our reading, the operation therefore needs an entity domiciled in Mexico with its own health license or notice. Which vehicle is best, and how it relates to the manufacturer and the marketing authorization holder, is reviewed case by case.

Is there a specific importers' registry for medicines?

Anyone who brings goods into Mexico must be enrolled in the Importers' Registry (Padrón de Importadores) and, where applicable, in the Specific-Sector Importers' Registry (Padrón de Importadores de Sectores Específicos), under article 59, section IV, of the Customs Law. In the version of Annex 10 of the General Foreign Trade Rules for 2026 published on January 14, 2026, we did not find a medicines sector. The version in force should be checked at the time of the operation.

Let us talk about your matter

Tell us what is happening and we will tell you whether it is a matter we can take on, what it would involve, and how the scope is defined.

A lawyer will review your matter and confirm the next step within 24 business hours.